Form 4: REGENXBIO Director Mills Exercises Stock Options, Acquires Shares
SEC Form 4 Filing
Director Kenneth T. Mills exercised stock options to acquire 36,316 shares of REGENXBIO Inc. at a price of $0.85 per share.
Summary
- On August 8, 2024, Kenneth T. Mills, a director of REGENXBIO Inc., exercised stock options.
- This transaction resulted in the acquisition of 36,316 shares of common stock at a price of $0.85 per share.
- Following the transaction, Mills directly owns 444,351 shares of REGENXBIO Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't convey any particularly positive or negative sentiment about the company's prospects.
Industry Context
This transaction is a routine disclosure of insider activity and doesn't necessarily indicate a significant shift in the company's outlook or performance. It reflects the director's decision to exercise previously granted stock options.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it involves the exercise of existing stock options by a director.
Key Dates
| Date | Description |
|---|---|
| 08/08/2024 | Date of transaction: Stock options exercised. |
| 08/12/2024 | Date of report filing. |
| 09/24/2024 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.